Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Contraindications: BPC-157 therapy is not appropriate for patients with active cancer, during pregnancy or breastfeeding, or for those on blood thinners (anticoagulants) without provider clearance
It suppresses NF-kB, which controls the expression of TNF-alpha along with dozens of other inflammatory mediators simultaneously
As cells age, mitochondria can become less efficient, leading to a decline in overall cellular function
If your B12 injections are covered under Part B, Medicare will pay 80% of the cost after you meet your $257 deductible
2021 May;16(5):1934578X211016649
The key to getting the most out of BPC-157 therapy is working with a qualified provider who uses human-grade medications, builds a personalized protocol, and supports your progress with the right nutritional guidance along the way
US$ 27.29
US$ 25.12
US$ 23.70
US$ 24.90
US$ 29.82
US$ 22.61
